Related Experiment Video

Updated: Jul 14, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
09:07

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

Published on: May 27, 2015

Granulocyte-macrophage colony-stimulating factor for Crohn's disease

Brendan Drumm, David Vaughan

    Lancet (London, England)
    |June 5, 2003
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Selective Harvesting of Marginating-hepatic Leukocytes
    06:53

    Selective Harvesting of Marginating-hepatic Leukocytes

    Published on: July 21, 2016

    Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
    09:04

    Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

    Published on: March 28, 2025

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
    09:07

    Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

    Published on: May 27, 2015

    Selective Harvesting of Marginating-hepatic Leukocytes
    06:53

    Selective Harvesting of Marginating-hepatic Leukocytes

    Published on: July 21, 2016

    Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus
    09:04

    Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

    Published on: March 28, 2025

    Related Concept Videos

    Cell-mediated Immune Responses01:40

    Cell-mediated Immune Responses

    Overview
    Cells of the Innate Immune Response01:28

    Cells of the Innate Immune Response

    The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
    Phagocytes
    Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
    Amebiasis01:28

    Amebiasis

    Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...

    Articles linked to this work by shared authors, journal, and citation graph.

    The Video Classification of Intubation (VCI) score for videolaryngoscopy: a multicentre international feasibility study.

    British journal of anaesthesia·2025

    Success of restoration strategies in preventing extirpation of 2 critically endangered coral species.

    Conservation biology : the journal of the Society for Conservation Biology·2025

    Surgical white matter disruption leads to downstream atrophy in the non-resected human brain.

    Brain : a journal of neurology·2025

    First seizure care in Australia and Aotearoa/New Zealand: health service needs for addressing the intersectoral global action plan in epilepsy.

    Epilepsy & behavior : E&B·2025

    Increased rates of invasive bacterial disease in late 2022.

    European journal of pediatrics·2023

    Post-translational dysregulation of glucose uptake during exhaustive cycling exercise in vastus lateralis muscle of healthy homozygous carriers of the ACE deletion allele.

    Frontiers in physiology·2022

    Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

    Lancet (London, England)·2026

    Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us